Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries by Voysey, M, Fanshawe, T, Kelly, D, O'Brien, K, Kandasamy, R, Shrestha, S, Thorson, S, Hinds, J, Pollard, A

“…These findings are important for global vaccination policy, to interrupt transmission by protecting against carriage.…”

Two centuries of immunisation in the UK (part 1) by Lang, S, Loving, S, McCarthy, N, Ramsay, M, Salisbury, D, Pollard, A

“…In Part 2, we discuss the formation of the Joint Committee on Vaccination and Immunisation and its role, working with public health agencies and advising the UK Governments on vaccine policy, to bring a comprehensive programme to defend the health of the population against serious infectious diseases, highlighting the importance of programme organisation and leadership.…”

Policy making for vaccine use as a driver of vaccine innovation and development in the developed world. by Seib, K, Pollard, A, de Wals, P, Andrews, R, Zhou, F, Hatchett, R, Pickering, L, Orenstein, W

“…We examine immunization vaccine policy as a driver of vaccine innovation and development. …”

Meningococcal disease and vaccination in North America. by Pollard, A, Scheifele, D

“…Although not currently an issue in industrialized nations, inclusion of serogroup A conjugates in any future vaccine policy would be an important decision in driving global prevention of meningococcal disease. …”